Brief: Seegene Introduces A High-Throughput 8-Plex Test For Flu A, Flu B, Rsv And Covid-19 With Dual Internal Controls
08/09/2020 13:14
Sept 8 (Reuters) - Seegene Inc 096530.KQ :
* SEEGENE INTRODUCES A HIGH-THROUGHPUT 8-PLEX TEST FOR FLU
A, FLU
B, RSV AND COVID-19 WITH DUAL INTERNAL CONTROLS
Source text for Eikon: ID:nPn499ltpa
Further company coverage: 096530.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seegene
See all newsBrief: Seegene To Cancel 174 Billion Won Worth Of Own Shares
Brief: Seegene Q4 Operating Profit 7 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Establishes French Subsidiary To Expand European Footprint
Brief: Seegene Q2 Operating Profit 3 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Q1 Operating Profit 14.8 Billion Won, Swings To Profit From Year Earlier